Creative Planning
SBIO icon

Creative Planning’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Creative Planning’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-300
Closed -$8K – 3372
2017
Q2 		$8K Buy
300
+100
+50% +$2.6K ﹤0.01% 3773
2017
Q1 		$5K Sell
200
-93
-32% -$2.31K ﹤0.01% 3971
2016
Q4 		$7K Hold
293
– – ﹤0.01% 3786
2016
Q3 		$8K Sell
293
-807
-73% -$20.1K ﹤0.01% 3662
2016
Q2 		$25K Sell
1,100
-780
-41% -$18.5K ﹤0.01% 2644
2016
Q1 		$41K Sell
1,880
-350
-16% -$8K ﹤0.01% 2234
2015
Q4 		$71K Sell
2,230
-2,800
-56% -$85.8K ﹤0.01% 1843
2015
Q3 		$140K Buy
+5,030
New +$176K ﹤0.01% 1387
2015
Q2 		– Sell
-1,600
Closed -$48K – 2650
2015
Q1 		$48K Buy
1,600
+1,200
+300% +$33.8K ﹤0.01% 2059
2014
Q4 		$10K Buy
+400
New +$9.94K ﹤0.01% 3129

Other funds holding SBIO

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCM
Barometer Capital Management Toronto, Ontario, Canada $292M AUM 86.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CT
Cambridge Trust Cambridge, Massachusetts $2.64B AUM 28.73% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Creative Planning's SBIO Position: Q3 2017 in Review

Creative Planning sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q3 2017, closing a stake of 300 shares — an estimated $8K sold.

Creative Planning first reported a position in SBIO in Q4 2014 and held it in 10 quarters. The position peaked at $140K in Q3 2015. 28 funds tracked by Wall St. Rank hold SBIO as of Q3 2017.

  • Creative Planning reported no remaining ALPS Medical Breakthroughs ETF position as of Q3 2017 after selling out during the quarter.
  • Creative Planning sold 300 ALPS Medical Breakthroughs ETF shares in Q3 2017, an estimated $8K.
  • Creative Planning first reported a position in ALPS Medical Breakthroughs ETF in Q4 2014 and held it in 10 quarters.
  • Creative Planning's ALPS Medical Breakthroughs ETF position peaked at $140K in Q3 2015.
  • 28 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.